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Abstract 68 
Our aim was to study the mechanisms that contribute to the development of discrete thalamic nuclei 69 
during mouse embryogenesis (both sexes included). We characterized the expression of the transcription 70 
factor coding gene Zic4 and the distribution of cells that expressed Zic4 in their lineage. We used genetic 71 
fate mapping to show that Zic4-lineage cells mainly contribute to a subset of thalamic nuclei, in particular 72 
the lateral geniculate nuclei, which are crucial components of the visual pathway. We observed that almost 73 
all Zic4-lineage diencephalic progenitors express the transcription factor Pax6 at variable location-74 
dependent levels. We used conditional mutagenesis to delete either one or both copies of Pax6 from Zic4-75 
lineage cells. We found that Zic4-lineage cells carrying either homozygous or heterozygous loss of Pax6 76 
contributed in abnormally high numbers to one or both of the main lateral geniculate nuclei. This could not 77 
be attributed to a change in cell production and was likely due to altered sorting of thalamic cells. Our 78 
results indicate that positional information encoded by the levels of Pax6 in diencephalic progenitors is an 79 
important determinant of the eventual locations of their daughter cells.  80 
 81 
Significance Statement 82 
The development of the thalamus is a process in which cells that initially appear similar give rise to distinct 83 
cell groups called nuclei. How these nuclei form is poorly understood. We utilised a mouse model in which 84 
cells that express the gene Zic4 can be followed. We studied the consequences of knocking out either one 85 
or both copies of the gene encoding the Pax6 transcription factor in these Zic4-lineage cells. We found that 86 
these mutations had significant effects on the contribution of Zic4-lineage cells to specifically visual 87 
thalamic nuclei. This was not attributable to a change in Zic4-lineage cell production in mutants. Rather, we 88 
suggest that mutation of Pax6 affects the distribution of Zic4-lineage neurons to specific thalamic nuclei.  89 
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Introduction 90 
The diencephalon is one of the two major components of the vertebrate forebrain. It contains several 91 
structures essential for brain function, including the thalamus and prethalamus. The thalamus is an 92 
important regulator of fundamental processes including sleep, alertness, consciousness and cognition, and 93 
is involved in the regulation of cortico-cortical communication and the relaying of sensory information to 94 
the cerebral cortex (Jones 2007; Sherman and Guillery, 2002, 2006, 2011). The thalamus is commonly 95 
subdivided into more than 40 distinct nuclei, distinguished according to their function, cytoarchitecture, 96 
anatomical connectivity and gene expression patterns (Jones, 2007; Martinez-Ferre and Martinez, 2012; 97 
Lim and Golden, 2007). For example, the lateral geniculate nucleus (LGN) is essential for the processing of 98 
visual information. The LGN is divided into two major components: the dorsal lateral geniculate nucleus 99 
(dLGN) relays visual signals from the retina to the visual cortex; the ventral lateral geniculate nucleus 100 
(vLGN) is involved in processing and integration, having inputs from retina, cortex and superior colliculus 101 
and connections to other thalamic nuclei.  102 
Thalamic nuclei develop in the mouse embryo during the final third of gestation as neurons generated from 103 
progenitors lining the third ventricle migrate radially into the thalamic mantle zone (Nakagawa and 104 
Shimogori, 2012). This process is likely to be regulated by the transcription factor Pax6, which is expressed 105 
by most diencephalic progenitors. The relatively few exceptions are located at the zona limitans 106 
intrathalamica (ZLI) between the thalamus and prethalamus (Ericson et al., 1997, Macdonald et al., 1995, 107 
Robertshaw et al., 2013; Caballero et al., 2014). The expression level of Pax6 varies systematically across 108 
the thalamus from high (caudally) to low (rostrally) and is high in the prethalamus. It can, therefore, confer 109 
positional identity on diencephalic progenitors, which might contribute to the ability of their daughter 110 
neurons to coalesce into discrete nuclei later in development.  111 
Zic4 is a zinc finger transcription factor expressed in embryonic mouse nervous system, including the 112 
diencephalon, from embryonic day (E) 9.5 on (Aruga et al., 1996a,b; Gaston-Massuet et al., 2005). A 113 
previous study reported that it is highly expressed in the postnatal LGN (Horng et al., 2009). We began our 114 
study by testing whether cells related by the expression of Zic4 at some time in their lineage (referred to as 115 
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Zic4-lineage cells) contribute selectively to specific thalamic nuclei. We carried out a detailed analysis of the 116 
development of both Zic4 expression and the distributions of Zic4-lineage cells in the embryonic 117 
diencephalon and found that Zic4-lineage cells are distributed preferentially to a select subset of thalamic 118 
nuclei, in particular the vLGN, by the time of birth. We then studied the consequences of Zic4Cre induced 119 
deletions of either one or both copies of Pax6.  120 
 121 
Materials and Methods 122 
Mice  123 
All experiments were conducted in accordance with Home Office UK regulations and University of 124 
Edinburgh animal welfare guidelines.  125 
Conditional Pax6 knockout mice were generated by crossing floxed Pax6 mutant mice Pax6fl/fl (Simpson et 126 
al., 2009) with Zic4Cre mice (Rubin et al., 2010), a kind gift from Dr Thomas Theil at Centre for Discovery 127 
Brain Sciences at the University of Edinburgh. These mice were crossed with RCE:loxP mice (Miyoshi et al., 128 
2010) to report the Cre activity with the expression of an enhanced green fluorescent protein (EGFP, 129 
subsequently referred to as GFP). The triple transgenic mice were maintained on a C57BL/6 background. To 130 
obtain Zic4Cre+/-;Pax6fl/fl;RCE+/-, Zic4Cre+/-;Pax6fl/+;RCE+/- and Zic4Cre+/-;Pax6+/+;RCE+/- embryos (subsequently 131 
referred to as Pax6fl/fl, Pax6fl/+ and Pax6+/+), Pax6fl/+;RCE+/- females were crossed with Pax6fl/+;Zic4Cre+/- males. 132 
To obtain Zic4Cre+/-;RCE+/- embryos, RCE+/- females were crossed with Zic4Cre+/- males.  133 
Genotyping 134 
Zic4Cre+/- mice were genotyped using primers (forward: GAGGGACTACCTCCTGTACC, reverse: 135 
TGCCCAGAGTCATCCTTGGC) to the iCre cassette (Rubin et al., 2010), resulting in a 630 bp PCR product in 136 
the mutant. RCE+/- mice were genotyped using three primers (Rosa1: CCCAAAGTCGCTCTGAGTTGTTATC; 137 
Rosa2: GAAGGAGCGGGAGAAATGGATATG and Cag3: CCAGGCGGGCCATTTACCGTAAG) to the EGFP reporter 138 
(Miyoshi et al., 2010), resulting in a 550 bp PCR product in the wild type and a 350 bp PCR product in the 139 
mutant. Mice carrying the Pax6fl transgene (Simpson et al., 2009) were genotyped using two primers 140 
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(FP6GtF: AAATGGGGGTGAAGTGTGAG, FP6GtR: TGCATGTTGCCTGAAAGAAG), resulting a 156 bp PCR 141 
product in the wild type and a 195 bp PCR product in the mutant. 142 
All Zic4Cre+/-;RCE+/-  embryos and pups were distinguished from wild type mice based on the detection of the 143 
GFP reporter using a GFP stereoscope and genotyped for the Pax6fl transgene using the primers described 144 
above.  145 
Tissue preparation and histology 146 
The day that the vaginal plug was found was considered as embryonic day 0.5 (E0.5). For postnatal studies, 147 
the birth date was considered as postnatal day 0 (P0). Embryos were extracted from pregnant females by 148 
caesarean section following an overdose of isoflurane and were harvested into ice cold phosphate buffered 149 
saline (PBS). For embryos aged from E11.5 to E14.5, whole heads were removed and fixed in 4% (w/v) 150 
paraformaldehyde (PFA) in PBS overnight at 4°C. For embryos aged from E15.5 to E18.5, brains were 151 
dissected from skulls before proceeding to fixation. P0 pups were anaesthetised by an overdose of sodium 152 
pentobarbitone and perfused with 4% PFA through the left ventricle of the heart. The brains were 153 
extracted and immersed in 4% PFA for 48 hours at 4°C. 154 
Fixed samples were either dehydrated in 70% EtOH and embedded in paraffin for microtome sectioning or 155 
cryo-protected in 30% sucrose (w/v) in PBS, embedded in a 1:1 mixture of 30% sucrose (w/v) in PBS and 156 
optimal cutting temperature (OCT) compound (Tissue-Tek, Sakura Finetek Europe, The Netherlands), and 157 
frozen on dry ice for cryostat sectioning. All samples were sectioned coronally at 10 μm.  158 
Fluorescent in situ hybridisation 159 
The digoxigenin (DIG)-labelled Zic4 antisense RNA probe was used at a concentration of 1:2000. 160 
Fluorescent in situ hybridisations were performed according to a published protocol (Rubin et al., 2010). 161 
The plasmid used to generate the Zic4 probe was the IMAGE clone 6400880 (linearised with EcoRI and 162 
transcribed with T3 RNA polymerase), a kind gift from Professor Nicoletta Kessaris, Wolfson Institute for 163 
Biomedical Research, University College London, UK.  164 
Immunohistochemistry 165 
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Fluorescent immunohistochemistry was performed on paraffin embedded sections according to previously 166 
published protocols (Martynoga et al., 2005). Diaminobenzidine (DAB) immunohistochemistry for Pax6 was 167 
performed using the Vectastain ABC kit (Vector Laboratories, Peterborough, UK) following an incubation of 168 
slides in biotinylated secondary antibodies and slides were incubated in 3% hydrogen peroxide/90% 169 
methanol for 30 min to inactivate endogenous peroxidase activities during the rehydration process. 170 
Primary antibodies used were as follow: mouse anti-BrdU IgG1 (1:150, BD Biosciences, RRID:AB_10015219), 171 
rabbit anti-Ki67 IgG (1:500, Abcam, RRID:AB_2049848), rabbit anti-pHH3 (Ser10) (1:100, Millipore, 172 
Burlington, Massachusetts, USA), mouse anti-Tuj1 IgG (1:400, Abcam, Cambridge, UK), goat anti-GFP IgG 173 
(1:150, Abcam), mouse anti-COUP-TFI IgG2A (1:500, R&D System, RRID:AB_1964211), mouse anti-COUP-TFII 174 
IgG2A (1:1000, R&D System, RRID:AB_1964214), mouse anti-LIM1/2 (1:50, Developmental Studies 175 
Hybridoma Bank [DSHB], University of Iowa, USA), mouse anti-Nkx2.2 (1:200, DSHB), mouse anti-Pax6 176 
(AD2.38) (a kind gift from Professor Veronica Van Heyningen at Institute of Genetics and Molecular 177 
Medicine, University of Edinburgh).  178 
Secondary antibodies used were donkey anti-goat Alexa Fluor 488 (1:200, Invitrogen, Carlsbad, California, 179 
USA), rabbit anti-mouse biotin (1:200, Vector Laboratories, Peterborough, UK), goat anti-rabbit biotin 180 
(1:200, Vector Laboratories), Streptavidin Alexa Fluor 594 (1:200, Invitrogen), donkey anti-mouse Alexa 181 
Fluor 568 (1:200, Invitrogen), donkey anti-mouse Alexa Fluor 647 (1:200, Invitrogen), donkey anti-rabbit 182 
Alexa Fluor 647 (1:200, Invitrogen). 183 
Bromodeoxyuridine (BrdU) labelling 184 
A single dose of BrdU (70 μg/g mouse weight, diluted in saline 10 μg/μl) was administrated via 185 
intraperitoneal injection to pregnant dams carrying E10.5, E11.5, E12.5 and E13.5 embryos. For birthdate 186 
studies, brain tissue was collected from four P0 Zic4Cre+/-;RCE+/-;Pax6+/+ pups for each injection age (E10.5 – 187 
E13.5). For cell proliferation studies, four embryos were collected for brain tissue 1.5 h after injection for 188 
each injection age (E11.5 – E12.5).  189 
Imaging, image processing and cell counting   190 
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DAB images were taken with a Leica DFC480 camera connected to a Leica DMNB epifluorescence 191 
microscope. Fluorescence images were taken with a Leica DM5500B automated upright microscope 192 
connected to a DFC360FX camera and a Nikon A1R confocal microscope.  193 
For birthdating studies, vLGN, dLGN and ventral posterior (VP) nuclei were outlined and processed in 194 
CellProfiler (Lamprecht et al., 2007) using a custom pipeline. RGB images were split into three single-195 
channel grey scale images and a global thresholding was performed to reduce background noises. Cell 196 
nuclei were identified using DAPI staining and a cut-off intensity value of 5 was used to distinguish nuclei 197 
with positive or negative staining for both BrdU and GFP. All cell nuclei were classified and automatically 198 
counted into four categories: GFP-BrdU-, GFP-BrdU+, GFP+BrdU+ and GFP+BrdU- and proportions of each 199 
category were calculated and exported into spreadsheets.  200 
For cell proliferation studies, a box with a fixed width was positioned and stretched to include the whole 201 
diencephalic wall for three structures of interest: the prethalamus and the pTH-R and pTH-C in the 202 
thalamus. Cropped images were processed in CellProfiler. Cell nuclei segmentation and fluorescence 203 
intensity measurements for BrdU, pHH3, Ki67, Tuj1 and GFP were performed as described above, with the 204 
same intensity cut-off applied ahead of cell counting.  205 
For cell contribution studies, volumes of vLGN, dLGN and VP were estimated using the ImageJ Volumest 206 
plugin (Merzin, 2008) using a series of ten coronal sections with a regular interval of 60 Pm. Within each 207 
section, nuclei were outlined and overlayed with a counting grid. 30% of counting tiles (30 Pm x 30 Pm) 208 
were randomly sampled using a custom ImageJ plugin (inspired by Wayne Rasband’s ImageJ plugin Grid) 209 
and manually counted to calculate densities of all cells and GFP+ cells. The number of all cells in each 210 
nucleus was calculated by multiplying its volume and cell density.  211 
Code accessibility 212 
Custom CellProfiler pipeline and ImageJ sampling tile generator plugin will be provided upon request. 213 
Statistical analyses  214 
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Statistical analyses were conducted using the Prism 7 statistical software (Version 7.01, GraphPad Software 215 
Inc.). Univariate statistics (means ± SEM) were performed for all studied variables. One-way ANOVA was 216 
performed to study the effect of genotype and two-way ANOVA was performed to examine the effects of 217 
genotype and anterior-posterior position. The Tukey post hoc test was performed for all pair-wise 218 
comparisons subsequent to the ANOVAs.  219 
 220 
Results 221 
Zic4 and Zic4Cre expression in the embryonic diencephalon 222 
We began by thoroughly analysing and comparing the expression of Zic4 transcripts and GFP reporter in the 223 
Zic4Cre+/-;RCE+/- diencephalon at embryonic stages from E11.5 to birth (Figs. 1-3). Whereas in situ 224 
hybridizations for Zic4 mRNA revealed the expression patterns of the gene at the time of analysis, GFP 225 
revealed cells that were either expressing or at some time in their past expressed Zic4 (Zic4-lineage cells). 226 
In the E11.5 diencephalon (Fig. 1A-F), Zic4 transcripts were detected at highest levels in cells of the 227 
prethalamus (Fig. 1C1,D1) and the eminentia thalami (Fig. 1B1). In the prethalamus, the Zic4 transcripts 228 
were concentrated in cells on the outer, pial side of the neuroepithelium (Fig. 1E). GFP expression 229 
overlapped that of Zic4 transcripts, with GFP+ cells most frequent in the prethalamus and the eminentia 230 
thalami (Fig. 1B2,C2,D2). GFP reporter activity did not correspond perfectly to the expression of Zic4 231 
transcripts, with many Zic4+ cells being GFP negative (Fig. 1E,F). The most likely explanation for this was 232 
that insufficient time had elapsed following the onset of Zic4 expression for the production of detectable 233 
levels of GFP. This delay would have been for the production of Cre recombinase from the Zic4Cre 234 
transgene, the consequent activation of the reporter gene and the production of sufficient GFP.  235 
At E12.5, Zic4 transcripts were present more widely, from epithalamus through thalamus and prethalamus 236 
to eminentia thalami (Fig. 1H1-J1). Expression levels were still highest in the prethalamus, as at E11.5, but 237 
were also strong in the epithalamus. In the thalamus, expression levels were highest in more anterior 238 
sections. GFP expression showed very similar patterns (Fig. 1H2-J2).  239 
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These E12.5 patterns of Zic4 and GFP expression were largely maintained as the tissues grew in size over 240 
subsequent days up to birth (Figs. 2,3). As thalamic nuclei formed during this period, Zic4/GFP+ cells 241 
became concentrated in the vLGN, around the border between the thalamus and prethalamus, in anterior 242 
thalamic regions and in the epithalamus. By birth, the densest concentration of GFP+ Zic4-lineage cells was 243 
in vLGN and the medial habenula of the epithalamus (Fig. 3H,I). Their densities were intermediate in other 244 
lateral thalamic nuclei such as the dLGN and in the zona incerta of the prethalamus. They were low in  245 
midline thalamic nuclei such as nucleus reuniens and the rhomboid nucleus, and almost absent from 246 
ventral posterior thalamic nuclei such as the ventral posterolateral nucleus (VPL) and ventral posteromedial 247 
nucleus (VPM) (Fig. 3H,I).  248 
These findings indicate that Zic4-lineage diencephalic progenitors contribute their daughter cells mainly to 249 
the thalamic nuclei that are close to the boundary between thalamus and prethalamus, particularly to the 250 
vLGN but also to others such as the dLGN.  251 
Overlap between Zic4-lineage and Pax6 expressing cells  252 
The normal expression pattern of Pax6 is shown at E12.5, E13.5, E14.5 and E16.5 in Figs. 4A1-F1,5A1-253 
G1,6A1-G1,7A1-F1. Pax6 is expressed at some level in almost all progenitors throughout the epithalamus, 254 
thalamus, prethalamus and eminentia thalami, the exceptions being located in the ZLI, a small strip of 255 
tissue between the thalamus and prethalamus (Fig. 4E1). In thalamus, it is distributed in a gradient with the 256 
lowest levels close to the border with the prethalamus (Figs. 4A1-E1, 5A1-E1). Since it is not expressed by 257 
postmitotic thalamic neurons, it almost completely disappears once the progenitor population is exhausted 258 
by E16.5 (Fig. 7A1-F1).  259 
In the prethalamus, Pax6 is strongly expressed by progenitors and is retained by many postmitotic cells as 260 
they migrate radially into the diencephalic mantle zone (Figs. 4A1-E1, 5A1-E1, 6A1-G1). These cells form a 261 
Pax6-positive strip running across the prethalamus. At early stages, some of them migrate as far as the 262 
outer edge of the neuroepithelium to a region where the vLGN will form (Fig. 5B1-E1,G1). By E14.5, when 263 
the development of discrete diencephalic nuclei is underway, most Pax6-expressing cells are located in the 264 
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zone incerta (ZI) of the prethalamus (Fig. 6A1-G1). At E14.5 and E16.5, we observed small numbers of Pax6-265 
expressing cells in the vicinity of the vLGN, mostly around rather than within it (Fig. 6E1-G1, 7D1-F1).  266 
As expected, given that Pax6 is expressed by almost all thalamic and prethalamic progenitors, double-label 267 
experiments showed that Zic4-lineage thalamic and prethalamic progenitor cells express Pax6 as early as 268 
E11.5 (Fig. 8). Many Zic4-lineage postmitotic cells in the prethalamus retained Pax6 (e.g. yellow asterisks in 269 
Fig. 8C); others did not (e.g. green asterisks in Fig. 8C). We went on to use the Zic4Cre allele to test the 270 
effects of mutating one or both copies of the Pax6 gene in Zic4-lineage cells.   271 
Zic4Cre-induced deletion of Pax6 272 
We studied Pax6 expression in Zic4Cre;Pax6fl/+ and Zic4Cre;Pax6fl/fl embryos at E12.5, E13.5, E14.5 and E16.5. 273 
For each genotype at each age, we examined three non-littermate embryos and the results were 274 
indistinguishable. In Zic4Cre;Pax6fl/fl homozygous mutant embryos (Fig. 4A3-F3,5A3-G3,6A3-G3,7A3-F3), the 275 
numbers of cells immunostained for Pax6 declined rapidly in the thalamus from E12.5 onwards, particularly 276 
in its anterior parts where many cells are Zic4-lineage. By E14.5, there were almost no Pax6-expressing 277 
progenitors in the thalamus in Zic4Cre;Pax6fl/fl embryos whereas normally a small population remained. The 278 
numbers of Pax6-expressing cells in the prethalamus of Zic4Cre;Pax6fl/fl embryos were greatly reduced at all 279 
ages. There were no consistent defects in the overall shapes and sizes of diencephalic structures.  280 
In Zic4Cre;Pax6fl/+ heterozygotes, we detected no defects of Pax6 expression at E12.5-E14.5 (Fig. 4A2-F2,5A2-281 
G2,6A2-G2). By E16.5, however, the numbers of Pax6-expressing cells had declined throughout the 282 
prethalamus and the intensity of the immunostaining of many Pax6-expressing cells was lower than normal 283 
(Fig. 7A2-F2). The pattern of Pax6 expression in Zic4Cre;Pax6fl/+ embryos now appeared intermediate 284 
between controls and Zic4Cre;Pax6fl/fl embryos. There were no detectable defects in the positions of the 285 
Pax6-expressing cells. The overall shapes and sizes of diencephalic structures appeared normal. These 286 
findings indicate that mutation of one copy of Pax6 in Zic4-lineage cells causes them to lower their Pax6 287 
levels between E14.5 and E16.5, i.e. once they are postmitotic neurons, with levels in some falling below 288 
the threshold for detection.  289 
Cells of the vLGN, dLGN and the ventral posterior nuclei are generated before E14.5  290 
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We selected three thalamic nuclei to search for defects resulting from mutation of Pax6 in Zic4-lineage 291 
cells: vLGN, which contains a large proportion of Zic4-lineage cells at birth; dLGN, which contains an 292 
intermediate proportion of Zic4-lineage cells at birth; ventral posterior (VP) nuclei (VPM and VPL), which 293 
contain low numbers of Zic4-lineage cells at birth.  294 
As a first step towards testing whether Pax6 mutation in Zic4-lineage cells affects the progenitors that give 295 
rise to these nuclei, we checked the ages at which vLGN, dLGN and VP cells are generated. We injected 296 
bromodeoxyuridine (BrdU) into control embryos at E10.5-E13.5 and studied BrdU labelling at birth (P0). To 297 
help identify the nuclei we used several markers: COUP-TFI, COUP-TFII, LIM1/2 and Nkx2.2 (Fig. 9A-D). 298 
COUP-TFI is expressed across most of the thalamic nuclei including the vLGN, dLGN and VP. The expression 299 
level of COUP-TFI in the vLGN is lower than the surrounding nuclei such as the dLGN and VP and, within the 300 
vLGN, is highest in the middle of the nucleus (Fig. 9A). COUP-TFII is expressed strongly in the prethalamus 301 
and helped determine the anterior boundaries of the vLGN and VP (Fig. 9C). LIM1/2 and Nkx2.2 are strongly 302 
expressed in the vLGN but not in the dLGN or VP (Fig. 9B,D). 303 
We counted BrdU labelled cells as a proportion of all cells and as a proportion of Zic4-lineage (GFP+) cells in 304 
each nucleus (Fig. 9E,F). We found that the vast majority of cells in vLGN, dLGN and VP are generated after 305 
E10.5 and before E13.5 (Fig. 9G,H). 306 
Effects of Pax6 mutation in Zic4-lineage cells on cell production  307 
We next used immunostaining for Ki67 (a marker of proliferating cells), Tuj1 (a marker of newly 308 
differentiating neurons) and phosphohistone H3 (pHH3, a marker of cells in M-phase of the cell cycle) 309 
together with short-term BrdU labelling to assess the activity of progenitors in regions that generate vLGN, 310 
dLGN and VP at E11.5 and E12.5 (Fig. 10). We made measurements in three regions: pTH-C, which gives rise 311 
to thalamic nuclei including dLGN and VP; pTH-R, which contributes to nuclei including vLGN; and 312 
prethalamus (Fig. 10A). We sampled from four sections through each prethalamus and five through each 313 
pTH-C and pTH-R, equally-spaced from anterior to posterior, from four embryos of each age and genotype.  314 
We first made measurements on all cells in the three regions, i.e. including both GFP+ and GFP- cells. When 315 
we examined the percentages of all cells that were proliferative based on their expression of Ki67, referred 316 
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to as the growth fraction, we found small but significant decreases in Pax6fl/fl pTH-C and pTH-R (Fig. 10B). 317 
When we measured this same parameter specifically in GFP+ (Zic4-lineage) cells, we found no significant 318 
effects of genotype (Fig. 10C). There were no inter-genotypic differences in the numbers of pHH3+ cells in 319 
any region at either age (Fig. 10D,E). We then measured the proportions of proliferating cells (Ki67+) that 320 
were in S-phase (BrdU+), which is an indication of their rate of proliferation (i.e. the longer the cell cycle, 321 
the lower the proportion of cells in S-Phase within the defined time-window). When we examined all cells 322 
we identified a small but significant decrease at E11.5 in Pax6fl/fl pTH-R (Fig. 10F). When we examined GFP+ 323 
cells alone, we found no significant effects of genotype (Fig. 10G). 324 
These findings indicate that the loss of both copies of Pax6 in Zic4-lineage has a minor effect on 325 
proliferation, causing decreases in pTH-C and/or pTH-R at some ages, which was only detectable in the 326 
overall population of progenitors and not specifically the Zic4-lineage progenitors themselves.     327 
Pax6 mutation in Zic4-lineage cells increases their contribution to vLGN and dLGN 328 
We then analysed the effects of Pax6 mutation in Zic4-lineage cells on the numbers of these cells that 329 
contribute to vLGN, dLGN and VP at P0 (Fig. 11). We first estimated the total numbers of cells in each of 330 
these nuclei by sampling the densities of all counterstained cells in each nucleus and multiplying by its 331 
volume. Volumes were estimated using the ImageJ Volumest plugin on a series of ten coronal sections with 332 
a regular interval of 60 μm from each brain sample. We found no significant inter-genotypic differences, 333 
indicating that Pax6 mutation in Zic4-lineage cells did not alter overall numbers of cells contributing to 334 
these nuclei (Fig. 11D-F).  335 
We measured the proportions of cells in each of these nuclei that were Zic4-lineage (i.e. GFP+). We found 336 
that these proportions were significantly increased in the dLGN of Pax6fl/fl embryos (Fig. 11A,C,H). They 337 
were increased even more in the dLGN of Pax6fl/+ embryos, with more than twice the normal proportions of 338 
Zic4-lineage cells contributing (Fig. 11A,B,H). Proportions were also increased in the vLGN of Pax6fl/+ 339 
embryos (Fig. 11A,B,G). The increases in the dLGN were seen in anterior sections in Pax6fl/fl embryos and 340 
throughout all sections in Pax6fl/+ embryos (Fig. 11H). The increases in the vLGN in Pax6fl/+ embryos were 341 
greater in more posterior sections (Fig. 11G). There were no inter-genotypic differences in VP (Fig. 11I).  342 
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These findings indicate that the dLGN increases its content of Zic4-lineage cells at the expense of Zic4-non-343 
lineage cells if the Zic4-lineage cells are Pax6fl/fl or Pax6fl/+. The vLGN increases its content of Zic4-lineage 344 
cells at the expense of Zic4-non-lineage cells if the Zic4-lineage cells are Pax6fl/+.  345 
 346 
Discussion 347 
We have found that Zic4-lineage cells normally contribute ~50% of vLGN cells, ~25% of dLGN cells and ~10% 348 
of VP cells at birth. Heterozygosity for a loss-of-function mutation of Pax6 in Zic4-lineage cells greatly 349 
increased the contribution that these cells make to the vLGN and dLGN, but not the VP. Homozygosity for 350 
the same mutation had a smaller effect on the contribution of Zic4-lineage cells to the dLGN and no effect 351 
on contribution to vLGN and VP.  352 
These changes are most likely explained by a redistribution of mutant Zic4-lineage cells into the dLGN and 353 
vLGN. Our findings argue against an alternative explanation involving overproduction of mutant Zic4-354 
lineage cells. When we tested whether Pax6 mutation, either heterozygous or homozygous, had an effect 355 
on the early proliferation of specifically the Zic4-lineage progenitors, we found none. We did find slight 356 
decreases in proliferation in some regions at some ages when we considered the overall populations of 357 
progenitors, both Zic4-lineage and Zic4-non-lineage. These finding suggest that some change in the Zic4-358 
lineage cells, perhaps involving altered signalling, had a cell non-autonomous effect on the Zic4-non-lineage 359 
cells. It does not, however, provide a straightforward explanation for the increased numbers of mutant 360 
Zic4-lineage cells in the dLGN and vLGN. Another reason that redistribution of postmitotic cells is a more 361 
likely mechanism than altered production is that the effects of heterozygosity for Pax6 mutation on Pax6 362 
protein levels only became obvious in postmitotic cells and not in progenitors.  363 
Figure 12 summarizes our model. The ZLI and the two progenitor domains posterior to it, pTH-R and pTH-C 364 
(Fig. 12C,E), express substantially different sets of regulatory genes. For example, the ZLI expresses Shh, 365 
pTH-R expresses transcription factors such as Nkx2.2 and Asc1, and pTH-C expresses Neurog1 and Neurog2. 366 
Several previous fate mapping studies have used genetic tools to exploit these early gene expression 367 
patterns to link specific sets of progenitors with mature diencephalic nuclei (Vue et al., 2007, 2009; Suzuki-368 
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Hirano et al., 2011; Delauney et al., 2009; Jeong et al., 2011). These studies showed that the ZLI and 369 
adjacent pTH-R contribute to the vLGN whereas more caudal progenitors in pTH-C contribute progressively 370 
to more caudal thalamic nuclei. In other words, the relative positions of thalamic progenitors are well 371 
preserved in the spatial arrangement of the nuclei they generate. Pax6 is expressed in a gradient by 372 
thalamic progenitors, with its lowest levels in pTH-R and no expression in the ZLI (Fig. 12C,E). This means 373 
that the Zic4-lineage cells that distribute to the vLGN and dLGN are derived mainly from progenitors that 374 
express little or no Pax6. If homozygous or heterozygous mutation causes Zic4-lineage cells to lose or lower 375 
their levels of Pax6, then these cells or their daughters preferentially distribute to nuclei that are generated 376 
from progenitors that express little or no Pax6. This suggests that the positional information encoded by 377 
the levels of Pax6 in diencephalic progenitors is an important determinant of the eventual locations of their 378 
daughter cells.  379 
A likely mechanism by which Pax6 levels effect the distribution of diencephalic neurons is through its 380 
regulation of cell adhesion molecules that cause cells to sort on the basis of their intercellular interactions. 381 
It has long been appreciated in many different systems that cells aggregate if they have similar levels of 382 
cadherins (Foty and Steinberg, 2005; Halbleib and Nelson, 2006). In the postnatal mouse brain, different 383 
thalamic nuclei express distinct combinations of cadherins: for example, the vLGN and dLGN express 384 
Cadherin 5, 8 and 11 whereas VP expresses mainly Cadherin 6 and 11 (Suzuki et al., 1997; Hirano and 385 
Takeichi, 2012). Both in vivo and in vitro studies have shown that Pax6 can regulate molecules such as R-386 
cadherin, L1 cell adhesion molecule and N-CAM (Andrews and Mastick, 2003; Tyas et al., 2003; Meech et 387 
al., 1999; Stoykova et al., 1997; Holst et al., 1997; Edelman and Jones, 1995; Chalepakis et al., 1994).  388 
Why Zic4-lineage cells heterozygous for a mutation of Pax6 cause a greater redistribution of Zic4-lineage 389 
cells affecting both dLGN and vLGN is not clear. One possibility stems from our observation that 390 
heterozygosity has a relatively late effect on Pax6 levels in postmitotic neurons, which contribute mainly to 391 
the prethalamus. A reduction of Pax6 levels in migrating prethalamic neurons might allow significant 392 
numbers of these cells to migrate in an abnormal direction across the boundary from prethalamus into the 393 
vLGN and dLGN. The numbers that do this might be greater than the numbers that sort incorrectly 394 
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following loss of Pax6 from progenitors, as occurs in homozygous deletion. Progenitors might possess a 395 
degree of plasticity that allows them to compensate to some degree if they lose Pax6, thereby minimizing 396 
the consequences for later sorting of their postmitotic cells. 397 
Whatever the cause of the strong effect of Pax6 heterozygosity, this finding is particularly relevant to 398 
human disease caused by PAX6 haploinsufficiency. In humans, heterozygous loss-of-function mutations 399 
affecting PAX6 cause a disorder with an incidence of ~1/50,000 live births. Patients show a range of 400 
neurological and psychiatric symptoms including impaired auditory processing, verbal function and social 401 
cognition, autism and mental retardation and altered functional connectivity in intrinsic neural networks 402 
(Sisodiya et al., 2001; Free et al., 2003; Mitchell et al., 2003; Bamiou et al., 2007; Umeda et al., 2010; 403 
Ellison-Wright et al., 2004; Thompson et al., 2004; Pierce et al., 2014). These functional abnormalities are 404 
associated with structural defects of the cerebral cortex and its axonal tracts (Sisodiya et al., 2001). Mice 405 
with heterozygous loss-of-function mutations of Pax6 have rarely been used to explore possible 406 
pathologies underlying the neurological and psychiatric symptoms that patients experience. Although one 407 
study suggested a slight delay in the onset of corticogenesis in Pax6+/- embryos (Schmahl et al., 1993), other 408 
work found no abnormalities of cortical development in these mice (Mi et al., 2013). Almost nothing is 409 
reported on the effects of Pax6+/- heterozygosity on development of the diencephalon. Given that the dLGN 410 
is the relay nucleus for projections to the visual cortex, the findings of this study suggest that defects of the 411 
thalamus and geniculocortical pathway might be found in patients.    412 
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Figure legends 524 
 525 
Figure 1. Expression of Zic4 and activity of Zic4Cre in Zic4Cre+/-;RCE+/- mouse brain coronal sections at E11.5 526 
and E12.5. (A,G) Schematics of E11.5 and E12.5 mouse brain demarcating major subdivisions and sectioning 527 
planes. (B1-F,H1-J3) Zic4 fluorescent in situ hybridisation (monochrome in B1,C1,D1,H1,I1,J1 or red in 528 
B3,C3,D3,E,F,H3,I3,J3) and immunohistochemistry for GFP reporter of Zic4Cre activity (monochrome in 529 
B2,C2,D2,H2,I2,J2 or green in B3,C3,D3,E,F,H3,I3,J3) with DAPI counterstaining (blue). Box in D3 is shown in 530 
E; box in E is shown in F. Scale bars: B1-D3,H1-J3, 250 μm; E, 125 μm; F, 25 μm. Cx, cortex; cp, choroid 531 
plexus; MGE, medial ganglionic eminence; LGE, lateral ganglionic eminence; th, thalamus; pth, 532 
prethalamus; emt, eminentia thalami; epi, epithalamus. 533 
 534 
Figure 2. Expression of Zic4 and activity of Zic4Cre in Zic4Cre+/-;RCE+/- mouse brain coronal sections at E13.5, 535 
E14.5 and E15.5. (A,E,I) Schematics of E13.5, E14.5 and E15.5 mouse brain demarcating major subdivisions 536 
and sectioning planes. (B1-D3,F1-H3,J1-L3) Zic4 fluorescent in situ hybridisation (monochrome in 537 
B1,C1,D1,F1,G1,H1,J1,K1,L1 or red in B3,C3,D3,F3,G3,H3, J3,K3,L3) and immunohistochemistry for GFP 538 
reporter of Zic4Cre activity (monochrome in B2,C2,D2,F2,G2,H2,J2,K2,L2 or green in B3,C3,D3,F3,G3,H3, 539 
J3,K3,L3) with DAPI counterstaining (blue). Scale bars: 250 μm. vLGN, ventral lateral geniculate nucleus; th, 540 
thalamus; pth, prethalamus. 541 
 542 
Figure 3. Expression of Zic4 and activity of Zic4Cre in Zic4Cre+/-;RCE+/- mouse brain coronal sections at E16.5, 543 
E18.5 and postnatal day (P) 0. (A,E,H) Schematics of E16.5, E18.5 and P0 mouse brain demarcating major 544 
subdivisions and nuclei and sectioning planes. (B1-D3,F1-G3) Zic4 fluorescent in situ hybridisation 545 
(monochrome in B1,C1,D1,F1,G1 or red in B3,C3,D3,F3,G3) and immunohistochemistry for GFP reporter of 546 
Zic4Cre activity (monochrome in B2,C2,D2,F2,G2 or green in B3,C3,D3,F3,G3,I) with DAPI counterstaining 547 
(blue). Scale bars: B1-G3, 250 μm; I, 500 μm. Cx, cortex; dLGN, dorsal lateral geniculate nucleus; Hippo, 548 
hippocampus; LD, lateral dorsal nucleus; LH, lateral habenula; LP, lateral posterior nucleus; MD, medial 549 
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dorsal nucleus; MH, medial habenula; PO, posterior nucleus; pth, prethalamus; PV, paraventricular nucleus; 550 
RE, nucleus reunions; RH, rhomboid nucleus; SPF, subparafascicular thalamic nucleus; th, thalamus; VAL, 551 
ventral anterolateral nucleus; vLGN, ventral lateral geniculate nucleus; VM, ventromedial nucleus; VPL, 552 
ventral posterolateral nucleus; VPM = ventral posteromedial nucleus; vTel, ventral telencephalon; ZI, zona 553 
incerta. (H) Adapted from Allen Brain Atlas http://developingmouse.brain-map.org/. 554 
 555 
Figure 4. Pax6 expression in control and Pax6 mutant embryos at E12.5. Immunohistochemistry for Pax6 556 
on a set of sections cut through the diencephalon in similar planes of section to those shown in Figure 1. 557 
Boxed areas in B1-3 are enlarged in F1-3. ZLI, zona limitans intrathalamica; epi, epithalamus; th, thalamus; 558 
pth, prethalamus; emt, eminentia thalami; h, hypothalamus. Scale bars, A1-E3, 500 μm; F1-3, 50 μm.    559 
 560 
Figure 5. Pax6 expression in control and Pax6 mutant embryos at E13.5. Immunohistochemistry for Pax6 561 
on a set of sections cut through the diencephalon in similar planes of section to those shown in Figure 2. 562 
Boxed areas in A1-B3 are enlarged in F1-G3. vLGN, ventral lateral geniculate nucleus; epi, epithalamus; th, 563 
thalamus; pth, prethalamus; emt, eminentia thalami; h, hypothalamus. Scale bars, A1-E3, 500 μm; F1-3, 50 564 
μm.    565 
 566 
Figure 6. Pax6 expression in control and Pax6 mutant embryos at E14.5. Immunohistochemistry for Pax6 567 
on a set of sections cut through the diencephalon in similar planes of section to those shown in Figure 2. ZI, 568 
zona incerta; vLGN, ventral lateral geniculate nucleus; th, thalamus; pth, prethalamus; emt, eminentia 569 
thalami. Scale bar, 500 μm.    570 
 571 
Figure 7. Pax6 expression in control and Pax6 mutant embryos at E16.5. Immunohistochemistry for Pax6 572 
on a set of sections cut through the diencephalon in similar planes of section to those shown in Figure 3. ZI, 573 
zona incerta; vLGN, ventral lateral geniculate nucleus; th, thalamus; pth, prethalamus. Scale bar, 500 μm.    574 
 25 
 
 575 
Figure 8. Diencephalic Zic4-lineage cells express Pax6. Double-immunohistochemistry for GFP (Zic4-lineage 576 
cells) and Pax6 at E11.5. Area outlined in B is enlarged in C. Asterisks in C: yellow, examples of double-577 
labelled cells; green, examples of cells labelled only with GFP. Scale bars: A, 250 μm; B, 50 μm; C, 10 μm. 578 
 579 
Figure 9. Birthdates of cells in the vLGN, dLGN and VP. (A-D) Immunohistochemistry at P0 with markers 580 
designed to help delineate borders of the thalamic nuclei analysed here. Scale bar, 100μm. (E,F) Example of 581 
BrdU and GFP immunohistochemistry in vLGN. Scale bars, E, 100 μm; F, 10 μm. (G) Proportions of all cells in 582 
each nucleus that were BrdU+ after injection with BrdU at E10.5-13.5. (H) Proportions of GFP-expressing 583 
cells in each nucleus that were BrdU+ after injection with BrdU at E10.5-13.5. Data points are from 584 
individual animals. Means ± sem are shown in each case. One-way ANOVA returned significant effects of 585 
age in all cases: (G) vLGN F(3,12)=7.729, P=0.0039; dLGN F(3,12)=13.56, P=0.0004; VP F(3,12)=20.76, 586 
P<0.0001. (H) vLGN F(3,12)=8.282, P=0.0030; dLGN F(3,12)=15.41, P=0.0002; VP F(3,12)=23.26, P<0.0001. 587 
Holm-Sidak’s multiple comparisons tests were performed following one-way ANOVA: *P < 0.05; **P < 0.01; 588 
***P < 0.001; **** P < 0.0001.   589 
 590 
Figure 10. Effects of Pax6 mutation in Zic4-lineage cells on early diencephalic progenitor proliferation. (A) 591 
Triple immunostaining for Tuj1, Ki67 and GFP. Three regions of interest were selected for analysis, one 592 
midway through pTH-C, one in pTH-R and one in prethalamus (pth). Scale bars, 50 μm. (B) Average growth 593 
fractions (± sem) in five equally spaced sections through pTH-C and pTH-R and four through prethalamus at 594 
E11.5 and E12.5; colour coding for genotypes as in E. Two-way ANOVA detected significant effects of 595 
genotype only in pTH-C (F(2,30)=9.109, P=0.0008) and pTH-R (F(2,30)=11.97, P=0.0002) at E12.5 (n = 3 596 
embryos of each genotype), with Pax6fl/fl embryos showing lower growth fractions at all levels (post hoc 597 
Tukey’s multiple comparisons test, P<0.01 at all positions). (C) Average growth fraction for GFP+ cells only. 598 
There were no significant effects of genotype. (D) An example of triple immunostaining for pHH3, BrdU and 599 
GFP in one region of interest. (E) Mean (± sem) counts of the total numbers of pHH3+ cells in all sampling 600 
 26 
 
regions from each domain for each genotype. There were no significant effects of genotype. (F) Average 601 
proliferation rates (± sem) in five equally spaced sections through pTH-C and pTH-R and four through 602 
prethalamus at E11.5 and E12.5; colour coding for genotypes as in E. Two-way ANOVA showed a significant 603 
effect of genotype in pTH-R at E11.5 (F(2,30)=4.206, P=0.0245), with lower values in Pax6fl/+ embryos than 604 
in the other two genotypes. (G) Average proliferation rates for GFP+ cells only. There were no significant 605 
effects of genotype. 606 
 607 
Figure 11. Pax6 mutation in Zic4-lineage cells increases their contribution to vLGN and dLGN. (A-C) 608 
Sections from rostral to caudal through the diencephalon of P0 Zic4Cre;Pax6+/+, Zic4Cre;Pax6fl/+ and 609 
Zic4Cre;Pax6fl/fl embryos. Scale bar 750 μm. (D-F) Total numbers of cells in vLGN, dLGN and VP in four P0 610 
pups of each genotype; individual values, means ± sem are shown. There were no significant effects of 611 
genotype. (G-I) Proportions of GFP+ (i.e. Zic4-lineage) cells in sections equally spaced through the vLGN, 612 
dLGN and VP of P0 Zic4Cre;Pax6+/+, Zic4Cre;Pax6fl/+ and Zic4Cre;Pax6fl/fl pups. In vLGN and dLGN, two-way 613 
ANOVA showed significant effects of genotype: vLGN, F(2,90)=23.98, P<0.0001; dLGN, F(2,60)=140.4, 614 
P<0.0001. In VP, there were no significant effects. Data are plotted using means and sems using at least 615 
three pups of each genotype (n = 4 for vLGN and n = 3 for dLGN and VP). 616 
 617 
Figure 12.  Model. (A,B) Sections through the embryonic thalamus (th) and prethalamus (pth) showing the 618 
locations of the zona limitans intrathalamica (ZLI; red) and pTH-R (dark blue). (C,D) Normally, Zic4-lineage 619 
cells from progenitors in the ZLI and pTH-R, which express little or no Pax6, contribute to the vLGN. Zic4-620 
lineage cells from progenitors in rostral pTH-C (i.e. close to pTH-R), whose levels of Pax6 are relatively low, 621 
contribute to dLGN.  Zic4-lineage cells in prethalamus (pth), which express Pax6 at high levels in both 622 
progenitors and postmitotic neurons, contribute to prethalamic regions including the zona incerta (ZI). (E,F) 623 
Mutant Zic4-lineage cells concentrate in the vLGN and/or dLGN, which are derived from thalamic 624 
progenitors that normally express little or no Pax6.  625 
 626 












